U.S. Residents Only, 18 Years and Older.
HOME
|
CONTACT US
|
INDEX
BMS.com-US
Study Connect Home
About Clinical Studies
What is a clinical study?
Who can participate?
Are there any risks to participants?
What investigational drug names are used in clinical study listings
Understanding clinical study phases
What is Informed Consent?
How are participants protected?
Clinical Study Insights
Pediatric Clinical Studies
Why are pediatric clinical studies important?
Video Gallery: What people are saying
Informed consent in pediatric studies
Caregivers
Some considerations for caregivers of study participants
Informed consent for caregivers
Caregiver resources
Clinical Study FAQs
Study ID (Protocol Number)
CA216-001
STUDY LOCATIONS*
Anthony El-Khoueiry, Md
Los Angeles, CA 90033
Recruiting
Local Institution
Houston, TX 77030
Not yet recruiting
Local Institution
Jackson, MS 39216
Not yet recruiting
Wayne State University
Detroit, MI 48201
Recruiting
*Not all study site locations may be listed - please check back soon for updated
information. For more information regarding other participating countries, please
visit
clinicaltrials.gov
.
STUDY NAME
Study to Evaluate the Safety and
Tolerability
of Weekly
IV
Doses of BMS-906024 in
Subjects
With Advanced or
Metastatic
Solid Tumors
STUDY OVERVIEW
The purpose of this study is to identify a safe and
tolerable dose
of BMS-906024 in
subjects
with advanced or
metastatic
solid tumors who no longer respond to or have
relapsed
from standard therapies.
The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit
ClinicalTrials.gov
for complete information about this and other clinical studies.